Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 8/20 | 0.61 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.61 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.55 |
| ▸ | CALCR | P30988 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29656041 | 0.97 | OPRD1 (0.61) | OPRD1OPRM1OPRK1CALCR | |
| SCHEMBL31688332 | 0.93 | OPRM1 (0.61) | OPRD1OPRM1OPRK1CALCR | |
| SCHEMBL29695551 | 0.89 | CALCR (0.62) | OPRD1OPRM1CALCR | |
| SCHEMBL29536416 | 0.89 | OPRD1 (0.66) | OPRD1OPRM1OPRK1CALCR | |
| SCHEMBL30906362 | 0.89 | KEAP1 (0.57) | OPRD1OPRM1OPRK1CALCR | |
| SCHEMBL29856023 | 0.88 | CALCR (0.61) | OPRD1OPRM1CALCR | |
| SCHEMBL29988048 | 0.88 | NPY2R (0.64) | CALCR | |
| SCHEMBL29610214 | 0.88 | CALCR (0.62) | OPRD1OPRM1OPRK1CALCR | |
| SCHEMBL31683333 | 0.88 | CALCR (0.60) | OPRD1OPRM1OPRK1CALCR | |
| SCHEMBL30906344 | 0.87 | KEAP1 (0.59) | CALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11344548-B2 | Analogs of 3,5-dihydroxypentanoate for bone formation | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2022-05-31 | — | — | US | claimed |
| US-11344548-B2 | Analogs of 3,5-dihydroxypentanoate for bone formation | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2022-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11344548-B2 | Analogs of 3,5-dihydroxypentanoate for bone formation | CYP24A1, CYP27B1, CYP2R1 | OPRD1 253/4885OPRM1 1518/4885OPRK1 322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.